3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Clinical and financial impact of chronic kidney disease in emergency general surgery operations

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          Chronic kidney disease is frequently encountered in clinical practice and often requires more intricate management strategies. However, its impact on outcomes of patients warranting emergency general surgery has not been well characterized. The present study examined the association of chronic kidney disease stage on in-hospital outcomes and readmission following emergency general surgery using a nationally representative cohort.

          Methods

          The 2016–2018 Nationwide Readmissions Database was queried to identify all adult hospitalizations for 1 of 6 common emergency general surgery operations. Patients were stratified by severity of chronic kidney disease into stages 1–3, stages 4–5, end-stage renal disease, and others (non chronic kidney disease ). Regression models were used to examine factors associated with mortality, readmissions, and costs.

          Results

          Of an estimated 985,101 patients undergoing emergency general surgery, 60,949 (6.2%) had a diagnosis of chronic kidney disease (1–3: 67.1%, 4–5: 11.5%, end-stage renal disease: 23.4%). Unadjusted rates of mortality increased with chronic kidney disease in a stepwise manner (2.1% in non chronic kidney disease to 16.9 in end-stage renal disease, P < .001), as did 90-day readmissions (9.2% to 29.7%, respectively, P < .001). After adjustment, all stages of chronic kidney disease exhibited increases in risk-adjusted rates of mortality (range: 0.2% in chronic kidney disease 1–3 to 12.2% in end-stage renal disease, P < .001). Relative to non chronic kidney disease, end-stage renal disease had the greatest cost burden for those undergoing small bowel resection ( β +$83,600) and the least in cholecystectomy (+$30,400).

          Conclusion

          Chronic kidney disease severity is associated with a stepwise increase in mortality, hospitalization costs, and 90-day readmissions. Our findings may better inform shared decision-making and have implications in benchmarking. Further studies for optimal management strategies in this high-risk group are needed.

          Related collections

          Most cited references16

          • Record: found
          • Abstract: not found
          • Article: not found

          Regression Shrinkage and Selection Via the Lasso

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The Economic Burden of Chronic Kidney Disease and End-Stage Renal Disease.

            The growing prevalence and progression of chronic kidney disease (CKD) raises concerns about our capacity to manage its economic burden to patients, caregivers, and society. The societal direct and indirect costs of CKD and end-stage renal disease are substantial and increase throughout disease progression. There is significant variability in the evidence about direct and indirect costs attributable to CKD and end-stage renal disease, with the most complete evidence concentrated on direct health care costs of patients with advanced to end-stage CKD. There are substantial gaps in evidence that need to be filled to inform clinical practice and policy.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The excess morbidity and mortality of emergency general surgery.

              Emergency general surgery (EGS) carries a disproportionate burden of risk from medical errors, complications, and death compared with non-EGS (NEGS). Previous studies have been limited by patient and procedure heterogeneity but suggest worse outcome in EGS patients because of preoperative risk factors. The aim of this study was to quantify the excess burden of morbidity and mortality associated with EGS by controlling for patient-specific factors. We hypothesized that EGS is an independent risk factor for morbidity and mortality.
                Bookmark

                Author and article information

                Contributors
                Journal
                Surg Open Sci
                Surg Open Sci
                Surgery Open Science
                Elsevier
                2589-8450
                07 June 2022
                October 2022
                07 June 2022
                : 10
                : 19-24
                Affiliations
                Cardiovascular Outcomes Research Laboratories (CORELAB), Division of Cardiac Surgery, University of California, Los Angeles David Geffen School of Medicine, Los Angeles, CA
                Author notes
                [* ]Corresponding author at: UCLA Division of Cardiac Surgery, 10833 Le Conte Ave, 64-249 CHS, Los Angeles, CA 90095. Tel.: + 1 310-206-6717; fax: + 1 310-206-5901. PBenharash@ 123456mednet.ucla.edu
                Article
                S2589-8450(22)00037-9
                10.1016/j.sopen.2022.05.013
                9283654
                35846391
                0caede69-dc2f-473f-9801-c65b87b298ca
                © 2022 The Authors

                This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

                History
                : 14 March 2022
                : 26 May 2022
                : 31 May 2022
                Categories
                Original Article

                Comments

                Comment on this article